The Use of NT-proBNP and BNP as Biomarkers of Acute Heart Failure
The Use of NT-proBNP and BNP as Biomarkers of Acute Heart Failure
The Use of NT-proBNP and BNP as Biomarkers of Acute Heart Failure
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Primary Endpoint<br />
100 events<br />
P =.009<br />
SOC<br />
<strong>NT</strong>-<strong>pro<strong>BNP</strong></strong><br />
58 events<br />
*Logistic Odds <strong>NT</strong>-<strong>pro<strong>BNP</strong></strong> = 0.44<br />
(95% CI= .22-.84; P =.019)<br />
*Adjusted for age, LVEF, NYHA Cl<strong>as</strong>s, <strong>and</strong> eGFR<br />
Source: Januzzi et al. clinicaltrialresults.org/Slides/PROTECT%20Presentation%20FINAL.ppt, accessed March 27, 2012<br />
29
Change language